AG

Anusha Gantla

Director Director DIN 09154471
DIN 09154471 First appointment Apr 2021 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Apr 2021
Shareholding value Locked Premium profile

About Anusha Gantla

Data last updated:

Anusha Gantla has 5 years in corporate governance. Formerly with 1 company, such as Kyragen Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 09154471
Primary Designation Director
First Appointment 21 Apr 2021
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Kyragen Pharma Private Limited U85300TG2021PTC150851
Director21 Apr 20212021Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Kyragen Pharma Private Limited
Premium access

Shareholding and investment profile for Anusha Gantla

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anusha Gantla

Anusha Gantla has 5 years in corporate governance. Formerly with 1 company, such as Kyragen Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Anusha Gantla is associated with 0 companies as a director.

Anusha Gantla has expertise in General Business.

Anusha Gantla has 5 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available